Reviewing Forte Biosciences (NASDAQ:FBRX) and Sycamore Entertainment Group (OTCMKTS:SEGI)

Sycamore Entertainment Group (OTCMKTS:SEGI) and Forte Biosciences (NASDAQ:FBRX) are both consumer discretionary companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, analyst recommendations, dividends, risk, earnings, valuation and institutional ownership.

Analyst Ratings

This is a breakdown of recent ratings and target prices for Sycamore Entertainment Group and Forte Biosciences, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sycamore Entertainment Group	0	0	0	0	0.00
Forte Biosciences	0	0	3	0	3.00

Forte Biosciences has a consensus target price of $3.25, suggesting a potential downside of 42.68%. Given Forte Biosciences’ stronger consensus rating and higher probable upside, analysts clearly believe Forte Biosciences is more favorable than Sycamore Entertainment Group.

Profitability

This table compares Sycamore Entertainment Group and Forte Biosciences’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Sycamore Entertainment Group	N/A	N/A	N/A
Forte Biosciences	N/A	-117.85%	-98.67%

Valuation & Earnings

This table compares Sycamore Entertainment Group and Forte Biosciences”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sycamore Entertainment Group	N/A	N/A	N/A	N/A	N/A
Forte Biosciences	N/A	N/A	-$31.48 million	($18.25)	-0.31

Insider & Institutional Ownership

77.6% of Forte Biosciences shares are held by institutional investors. 75.5% of Sycamore Entertainment Group shares are held by company insiders. Comparatively, 9.6% of Forte Biosciences shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Risk and Volatility

Sycamore Entertainment Group has a beta of 49.22, meaning that its stock price is 4,822% more volatile than the S&P 500. Comparatively, Forte Biosciences has a beta of 0.04, meaning that its stock price is 96% less volatile than the S&P 500.

About Sycamore Entertainment Group

Sycamore Entertainment Group, Inc., a diversified entertainment company, which specializes in the acquisition, marketing, and worldwide distribution of feature-length motion pictures. The company is based in Seattle, Washington.

About Forte Biosciences

Forte Biosciences, Inc. operates as a biopharmaceutical company in the United States. The company is developing FB-102 program that addresses various autoimmune diseases, such as graft-versus-host disease, and vitiligo and alopecia areata. Forte Biosciences, Inc. is headquartered in Dallas, Texas.